Burling Wealth Partners LLC Sells 172 Shares of Intuitive Surgical, Inc. $ISRG

Burling Wealth Partners LLC lowered its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 16.2% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 892 shares of the medical equipment provider’s stock after selling 172 shares during the period. Burling Wealth Partners LLC’s holdings in Intuitive Surgical were worth $485,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Tobam boosted its holdings in shares of Intuitive Surgical by 666.7% in the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 40 shares during the last quarter. TD Capital Management LLC raised its position in Intuitive Surgical by 300.0% in the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 45 shares during the period. 1248 Management LLC purchased a new position in Intuitive Surgical in the first quarter valued at about $30,000. Princeton Global Asset Management LLC bought a new position in shares of Intuitive Surgical during the 2nd quarter valued at approximately $30,000. Finally, Bank of Jackson Hole Trust increased its stake in shares of Intuitive Surgical by 70.5% during the 1st quarter. Bank of Jackson Hole Trust now owns 75 shares of the medical equipment provider’s stock worth $37,000 after purchasing an additional 31 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, VP Fredrik Widman sold 2,067 shares of the stock in a transaction that occurred on Wednesday, November 5th. The shares were sold at an average price of $550.00, for a total value of $1,136,850.00. Following the sale, the vice president directly owned 473 shares in the company, valued at $260,150. This represents a 81.38% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Myriam Curet sold 105 shares of the firm’s stock in a transaction on Monday, November 10th. The shares were sold at an average price of $560.00, for a total transaction of $58,800.00. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 116,164 shares of company stock worth $61,916,172 in the last ninety days. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Down 2.8%

Shares of NASDAQ ISRG opened at $549.51 on Friday. The company has a market cap of $196.99 billion, a P/E ratio of 72.69, a P/E/G ratio of 4.94 and a beta of 1.62. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The business has a 50-day simple moving average of $482.51 and a two-hundred day simple moving average of $503.18.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, beating the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The firm had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.41 billion. During the same period in the prior year, the business posted $1.84 earnings per share. The company’s revenue was up 22.9% on a year-over-year basis. Equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on the company. Piper Sandler upped their price objective on Intuitive Surgical from $595.00 to $610.00 and gave the company an “overweight” rating in a research note on Wednesday, October 22nd. Royal Bank Of Canada set a $625.00 price objective on Intuitive Surgical and gave the company an “outperform” rating in a research note on Wednesday, October 22nd. Argus upped their price objective on shares of Intuitive Surgical from $600.00 to $630.00 in a report on Monday, October 27th. Zacks Research upgraded shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research note on Friday, October 24th. Finally, Raymond James Financial set a $603.00 price target on shares of Intuitive Surgical and gave the company an “outperform” rating in a research report on Wednesday, October 22nd. Two analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus price target of $608.92.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.